A Giant Drug Company That Doesn't Invent Medicines?
Brenton Saunders, chief of executive of pharmaceutical giant, Actavis, which is buying Allergan for $67B, says the new Actavis-Allergan will be a revolutionary new kind of drug company – one that does not invent drugs! Yes – you heard that right! The company will be the first big pharma to go this route, instead, preferring to buy them from universities or biotechs. Learn more about Saunders, and his new role of CEO of Actavis-Allergan here. (Source: Matthew Herper, Forbes, 1/21/15)